For other candidate genes, 67% of AML patients were also compound heterozygotes for RYR1 and FLG, whereas 50% of ALL patients were compound heterozygotes for RBMX. We next plotted the top 50 variant candidate genes for infants (Figure 2). This evidence concerns the gene FLG and acute lymphoblastic leukemia.